OTI-030

N/A

Report date: 2024/11/23 20:00:08

Base Information

Drug NameOTI-030
Drug Alias NameMesenchymal stem cell therapy for meniscal repairChondrogenOTI-030
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCartilage replacementsTissue replacementsStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMeniscus InjuriesOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMalaysia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOsiris Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMesoblast International SarlMeluha Life Sciences
Active IndicationsN/A
Inactive IndicationsMeniscus InjuriesOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A